More on ILMN by Philip Davis
Latest ILMN Transcript
More »Latest ILMN Articles
-
Review Of Analyst Upgrades This Week - Part V
Thu, May 24 • Robert Broens
-
Top Healthcare Sector Buys And Sells In Billionaire Steven Cohen's Q1 Filing
Tue, May 22 • Ganaxi Small Cap Movers
-
Top 5 Biotech ETFs
Tue, May 15 • David Fry
-
6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or Better
Sun, May 13 • ZetaKap
-
Top High Growth Undervalued Medical Systems And Software Stocks Accumulated By Mega Funds
Sun, May 13 • Ganaxi Small Cap Movers
-
Isis: A Pick To Win The Biotech Derby
Thu, May 10 • Jessica King Holden
-
4 Highly Liquid Biotech Stocks With Bullish Short Trends
Thu, May 10 • Kapitall
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Illumina, Inc. (ILMN)
Posts on ILMN by Philip Davis
Premium Member Post: Orphan Drugs Are Good! BioMarin & Illumina
Posts on ILMN by other instabloggers
-
Mon, Apr 23
•
Jim Van Meerten
-
Fri, Apr 20
•
Tim Travis
-
Tue, Apr 17
•
New Low Observer
-
Mon, Apr 9
•
Charles Margolis
-
Tue, Feb 14
•
EXPstocktrader
All instablog posts on ILMN »Barchart Morning Call 4/23
Illumina CEO Has Year To Top Roche's $6.7 Billion Offer-Bloomberg
The Seemingly Random Nature of our Investment Strategy
Obamacare: Medical Management Without Medicine
The Hepatitis C Gold Rush - Looking For The Right Fit For Idenix's Drug IDX184